Date published: 2025-10-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-755,507 (CAS 159182-43-1)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
L-755,507 is also known as a selective β3-adrenergic receptor partial agonist.
Application:
L-755,507 is a very potent, selective β3-adrenergic receptor partial agonist and enhancer of CRISPR-mediated HDR efficiency.
CAS Number:
159182-43-1
Purity:
≥97%
Molecular Weight:
584.73
Molecular Formula:
C30H40N4O6S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

L-755,507 is a compound that is utilized in research focused on the beta-3 adrenergic receptor. This receptor subtype is of interest due to its involvement in the regulation of energy expenditure and thermogenesis, primarily in adipose tissue. L-755,507 acts as an agonist at this receptor, and studies involving this compound aim to elucidate the signaling pathways and physiological outcomes of beta-3 adrenergic activation. In metabolic studies, L-755,507 is used to assess the potential for increasing metabolic rate and lipolysis. It also serves as a tool in the field of endocrinology to understand the mechanisms that might influence insulin sensitivity and glucose uptake. Research with L-755,507 aids in the exploration of metabolic conditions and contributes to the identification of targets for potential alterations in metabolic regulation.


L-755,507 (CAS 159182-43-1) References

  1. Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides.  |  Parmee, ER., et al. 1999. Bioorg Med Chem Lett. 9: 749-54. PMID: 10201841
  2. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes.  |  Kimura, K., et al. 2000. Horm Metab Res. 32: 91-6. PMID: 10786926
  3. Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice.  |  Kohout, TA., et al. 2001. Circulation. 104: 2485-91. PMID: 11705829
  4. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.  |  Sato, M., et al. 2008. Mol Pharmacol. 74: 1417-28. PMID: 18684840
  5. Do β3-adrenergic receptors play a role in guinea pig detrusor smooth muscle excitability and contractility?  |  Afeli, SA., et al. 2012. Am J Physiol Renal Physiol. 302: F251-63. PMID: 21993887
  6. The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells.  |  Mason, RP., et al. 2013. BMC Pharmacol Toxicol. 14: 48. PMID: 24074014
  7. Small molecules enhance CRISPR genome editing in pluripotent stem cells.  |  Yu, C., et al. 2015. Cell Stem Cell. 16: 142-7. PMID: 25658371
  8. Programmable DNA repair with CRISPRa/i enhanced homology-directed repair efficiency with a single Cas9.  |  Ye, L., et al. 2018. Cell Discov. 4: 46. PMID: 30062046
  9. A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells.  |  Singh, A., et al. 2021. J Biol Chem. 297: 100903. PMID: 34157284
  10. Modification of improved-genome editing via oviductal nucleic acids delivery (i-GONAD)-mediated knock-in in rats.  |  Aoshima, T., et al. 2021. BMC Biotechnol. 21: 63. PMID: 34724929
  11. An effective double gene knock-in strategy using small-molecule L755507 in the medaka fish (Oryzias latipes).  |  Murakami, Y. and Kobayashi, T. 2022. Genesis. 60: e23465. PMID: 35072325
  12. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.  |  Fisher, MH., et al. 1998. J Clin Invest. 101: 2387-93. PMID: 9616210
  13. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.  |  Parmee, ER., et al. 1998. Bioorg Med Chem Lett. 8: 1107-12. PMID: 9871717
  14. 3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.  |  Naylor, EM., et al. 1998. Bioorg Med Chem Lett. 8: 3087-92. PMID: 9873681
  15. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.  |  Umekawa, T., et al. 1999. Diabetes. 48: 117-20. PMID: 9892231

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

L-755,507, 10 mg

sc-204045
10 mg
$336.00

L-755,507, 50 mg

sc-204045A
50 mg
$877.00